These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 5847487)

  • 1. [Histological studies on the distribution of glycogen in ocular tumors].
    Kozuchowska I
    Klin Oczna; 1965; 35(3):411-5. PubMed ID: 5847487
    [No Abstract]   [Full Text] [Related]  

  • 2. Histological investigations on the distribution of glycogen in neoplasms of the eye.
    Kozuchowska I
    Pol Med J; 1966; 5(1):172-8. PubMed ID: 5934573
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cathepsin A activity in the vitreous body of patients with absolute glaucoma and intraocular tumors].
    Obuchowska I; Stankiewicz A; Bańkowski E
    Klin Oczna; 1999; 101(3):167-8. PubMed ID: 10526437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Angiogenesis factor in intraocular tumors].
    Barraquer RI; Domenech Mateu JM; Fernández Cotero JN; Muiños Muro SJ; Iglesias Touriño E
    Rev Esp Oncol; 1982; 29(3):413-21. PubMed ID: 6084270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.
    Hau P; Apfel R; Wiese P; Tschertner I; Blesch A; Bogdahn U
    Anticancer Res; 2002; 22(2A):577-83. PubMed ID: 12014625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of monocarboxylate transporter 1 in oral and ocular canine melanocytic tumors.
    Shimoyama Y; Akihara Y; Kirat D; Iwano H; Hirayama K; Kagawa Y; Ohmachi T; Matsuda K; Okamoto M; Kadosawa T; Yokota H; Taniyama H
    Vet Pathol; 2007 Jul; 44(4):449-57. PubMed ID: 17606506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences with a solid state detector for surface counting of phosphorus-32.
    Pircher FJ; Anderson B; Cavanaugh PJ; Sharp KW
    J Nucl Med; 1967 Jun; 8(6):444-50. PubMed ID: 6029290
    [No Abstract]   [Full Text] [Related]  

  • 8. HLA expression in choroidal melanomas: correlation with clinicopathological features.
    Krishnakumar S; Abhyankar D; Lakshmi SA; Pushparaj V; Shanmugam MP; Biswas J
    Curr Eye Res; 2004 Jun; 28(6):409-16. PubMed ID: 15512948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
    Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
    J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiostatin decreases cell migration and vascular endothelium growth factor (VEGF) to pigment epithelium derived factor (PEDF) RNA ratio in vitro and in a murine ocular melanoma model.
    Yang H; Xu Z; Iuvone PM; Grossniklaus HE
    Mol Vis; 2006 May; 12():511-7. PubMed ID: 16735992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma.
    Kvanta A; Steen B; Seregard S
    Exp Eye Res; 1996 Nov; 63(5):511-8. PubMed ID: 8994354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of prolonged ischemia upon regional energy reserves in the experimental glioblastoma.
    Kirsch WM; Schulz D; Leitner JW
    Cancer Res; 1967 Nov; 27(11):2212-20. PubMed ID: 6073511
    [No Abstract]   [Full Text] [Related]  

  • 14. Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunoistochemical C-KIT (CD 117): preliminary results of a compassionate use clinical trial.
    Fiorentini G; Rossi S; Lanzanova G; Biancalani M; Palomba A; Bernardeschi P; Dentico P; De Giorgi U
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):17-20. PubMed ID: 16767900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to exogenously added interferon-beta protein depends on intracellular interferon-beta mRNA level in human glioma cells.
    Osawa H; Mizuno M; Hatano M; Nakahara N; Tsuno T; Kuno T; Endo M; Yoshida J
    Cytokine; 2005 Dec; 32(5):240-5. PubMed ID: 16343929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth-related enzymatic control of glycogen metabolism in cultured human tumor cells.
    Rousset M; Paris H; Chevalier G; Terrain B; Murat JC; Zweibaum A
    Cancer Res; 1984 Jan; 44(1):154-60. PubMed ID: 6418376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ocular metastases of solid extraocular tumors. Frequency of ocular metastases and localization of the primary tumors].
    Królewska K; Palacz O; Zajaczek S
    Klin Oczna; 2004; 106(1-2):102-6. PubMed ID: 15218777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic ocular melanoma to the kidney 20 years after initial diagnosis.
    Levin BM; Boulos FI; Herrell SD
    Urology; 2005 Sep; 66(3):658. PubMed ID: 16140107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive acidic protein in intraocular fluids.
    Takeda Y; Yamaguchi K; Tamai M
    Jpn J Ophthalmol; 1994; 38(4):388-91. PubMed ID: 7723207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iridocorneal melanoma associated with type 1 neurofibromatosis: a clinicopathologic study.
    Rehany U; Rumelt S
    Ophthalmology; 1999 Mar; 106(3):614-8. PubMed ID: 10080223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.